We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.04 | -1.13% | 3.51 | 3.02 | 4.00 | - | 303,907 | 16:35:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 7.78M | 1.33M | 0.0045 | 7.89 | 10.48M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/5/2024 19:57 | but do remember to adhere to those thread rules in the header Dom | elpirata | |
14/5/2024 19:51 | Many thanks to the thread manager for reprieving this avatar from a death sentence! | dominiccummings | |
14/5/2024 17:04 | Not now, actually Dom. | goatherd | |
14/5/2024 11:39 | He shouldn’t expect anything - and then he won’t be (yet further) disappointed. | monte1 | |
14/5/2024 11:01 | Caneletto, Yes, huge news. But on Therapeutics. As you know Proteome is only working on diagnostics, so you should not expect a connection! | goatherd | |
14/5/2024 07:30 | Huge medical news on Breakfast TV this morning involving stroke and ADI must have missed the mention of Prm front and centre. | canaletto | |
13/5/2024 15:48 | Ah remember the days of CK1 Delta - alzheimers cure - if you are a mouse you have nothing to worry about any more. Remember the doctor who had never seen anything like proteome in terms of predicting cancer pathways etc. Sadly no more pie in the sky stuff. Would be nice to see their US research lab winning a load of business and taking them into long term profitability, if they could get up to USD 20m a year they may even pay off the CJP loan. | octopus100 | |
12/5/2024 19:25 | #92913 You miss the bit where the Chairman tells attendees what pub he's visiting after the AGM, so drummimg up the attendees to buy his Gin & Tonic! | dominiccummings | |
12/5/2024 16:02 | We will see,maybe just maybe they will pull something out of the hat. | peverill | |
12/5/2024 15:42 | I am not so sure peverill. I live in hope! | goatherd | |
12/5/2024 15:19 | The usual spiel,regurgitate some previous presentation with a new spin on it,you know the score Richard,you've done plenty of it and yet here we are,no further forward. | peverill | |
12/5/2024 15:04 | And what is she going to say in the webcast presentation? | goatherd | |
12/5/2024 14:50 | base7, Yes, I share some of your thoughts on that. BUT we have been there before. It could just be that the CEO got out of bed one morning and thought "Oh, its a long time since I made a presentation. Perhaps I should do one to show the shareholders I am earning my keep." I do prefer your version, but I fear they are both possible versions; and, of course, there are many more. | goatherd | |
12/5/2024 12:53 | AGM coming up,should last all of 20 minutes and see you all next year.And thanks for the steady wage and your patience. | peverill | |
11/5/2024 16:57 | Proteome Sciences AGM is next Thursday at midday. This is broadcast live on the 'investormeetcompany | pools2 | |
11/5/2024 16:16 | Interesting to note that there will be an Investor Meets next Thursday @ midday.These presentations usually take place within a day or two of results or following significant contract news.It will be 3 weeks after the recent RNS regarding the 500k contract, which I would not have thought would warrant a CEO presentation -so what might our CEO have to tell us next Thursday which we dont already know following results last month & the recent contract award ? The optimist in me hopes for an RNS ahead of Thursdays presentation which will explain clearly why our CEO considers it necessary to make a presentation. | base7 | |
10/5/2024 12:59 | One for those with long memories here - was it 2002 everyone starting getting excited about their biomarkers for this? | bluemango | |
08/5/2024 11:37 | wasjobber? | monte1 | |
08/5/2024 11:19 | SINGLE CELL PROTEOMICS (SCP) Over 1000 cells per day with TMTpro 32-plex | pools2 | |
04/5/2024 05:56 | As you were!! | peverill | |
01/5/2024 08:15 | Presumably the other secondary avatar wasjobber is being prepped to verify that to be the case as we 'speak'? | barry evans | |
01/5/2024 07:30 | I'm not sure investors fully appreciate the significance of Proteome Sciences new 32-plex TMTpro reagents, which will probably be officially announced by Thermo at this years ASMS in Anaheim early next month. It's not just a near doubling of the current 18-plex TMTpro reagent, but also a massive improvement of Thermo's mass spec capabilities, which will leave their competitors far behind them in performance and sample throughput. One users perspective :- www.proteomicsnews.b The new 32-plex TMTpro reagents will have big consequences for the mass spec proteomics market and its competitors. | pools2 | |
28/4/2024 17:18 | Thermo Fisher Scientific Reports First Quarter 2024 Results24th April 24Source: Business WireThermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024.First Quarter 2024 HighlightsFirst quarter revenue was $10.34 billion.First quarter GAAP diluted earnings per share (EPS) increased 4% to $3.46.First quarter adjusted EPS increased 2% to $5.11. | goggin | |
26/4/2024 21:41 | 10p-ish...Ha! i suspect that gave The Diggles, the giggles. ~40Mln buyout after 30 years-ish.......The mind boggles. | cdlaney |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions